ShareHope Medicine Co., Ltd. (TPEX:8403)
23.35
+0.05 (0.21%)
Dec 31, 2025, 2:31 PM CST
ShareHope Medicine Market Cap
ShareHope Medicine has a market cap or net worth of 3.21 billion as of December 31, 2025. Its market cap has decreased by -15.16% in one year.
Market Cap
3.21B
Enterprise Value
3.78B
Revenue
4.34B
Ranking
n/a
PE Ratio
18.27
Stock Price
23.35
Market Cap Chart
Since December 24, 2008, ShareHope Medicine's market cap has increased from 525.00M to 3.21B, an increase of 512.17%. That is a compound annual growth rate of 11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.21B | -15.31% |
| Dec 31, 2024 | 3.79B | -8.49% |
| Dec 29, 2023 | 4.15B | 2.20% |
| Dec 30, 2022 | 4.06B | 31.44% |
| Dec 30, 2021 | 3.09B | -18.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |